ArticlePhenomics (Cham, Switzerland)2025

Baseline Plasma GPX3 Level Predicts Efficacy of Insulin-Sensitization Drug Chiglitazar in Type 2 Diabetes.

Zehui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.